SomnoMed Ltd (ASX: SOM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

SomnoMed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $68.13 million
P/E Ratio 136.99
Dividend Yield 0.00%
Shares Outstanding 219.77 million
Earnings per share -0.012
Dividend per share N/A
Year To Date Return -58.58%
Earnings Yield 0.73%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • SomnoMed Ltd (ASX: SOM)
    Latest News

    A man in a suit looks surprised as he looks through binoculars.
    Broker Notes

    These 3 ASX shares are on my watchlist for 2027

    I've been on the hunt for value on the ASX.

    Read more »

    Doctor with stethoscope holding a tablet and smiling.
    Healthcare Shares

    ASX healthcare shares are 39% higher since June. Are you missing out?

    Healthcare stocks endured a long slump before the sector pivoted three months ago.

    Read more »

    Happy man working on his laptop.
    Small Cap Shares

    Morgans names 3 small-cap ASX shares to buy

    Let's see why the broker is bullish on these under the radar shares.

    Read more »

    Three health professionals at a hospital smile for the camera.
    Healthcare Shares

    3 ASX healthcare stocks soaring on positive company updates

    These companies have exciting news for investors today.

    Read more »

    In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
    Earnings Results

    2 small ASX healthcare shares sprouting green after FY24 results

    Healthcare stocks continue to show strong results in FY24.

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Share Fallers

    Why Cardno, Mesoblast, Perseus, and Somnomed shares are dropping today

    These ASX shares are having a tough hump day. But why?

    Read more »

    ASX Share Market News

    What's behind the sleepy Somnomed (ASX:SOM) share price?

    The Somnomed share price dipped more than 2% lower today. We look at the company's current position and consider the…

    Read more »

    Share Gainers

    Rhinomed (ASX:RNO) share price tries following Starpharma's path to COVID glory

    The Rhinomed Ltd (ASX: RNO) share price surged to a six-month high as it takes a leaf out of the…

    Read more »

    a woman
    ASX Share Market News

    SomnoMed share price rises after reporting positive earnings

    The SomnoMed Limited (ASX: SOM) share price has risen today after the company reported its half-year earnings.

    Read more »

    a woman
    52-Week Highs

    Why the SomnoMed share price is at a 52-week-high

    The SomnoMed Limited (ASX: SOM) share price has closed at a 52-week-high after making a spectacular recovery over the last…

    Read more »

    a woman
    Share Gainers

    ALL ORDINARIES finishes higher Tuesday: 8 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Tuesday.

    Read more »

    a woman
    ASX Share Market News

    Is the Somnomed share price a turnaround story?

    Somnomed Limited (ASX: SOM) has restructured its sales and reports its outlook is "very positive".

    Read more »

    SOM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About SomnoMed Ltd

    SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. The company was founded on March 16, 1987 and is headquartered in Sydney, Australia.

    SOM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Nov 2026 $0.32 $0.03 10.34% 23,544 $0.32 $0.32 $0.31
    11 Nov 2026 $0.29 $0.00 0.00% 1,293 $0.29 $0.29 $0.29
    10 Nov 2026 $0.29 $0.01 3.57% 7,000 $0.29 $0.29 $0.29
    09 Nov 2026 $0.28 $-0.01 -3.45% 13,187 $0.30 $0.30 $0.28
    06 Nov 2026 $0.29 $-0.02 -6.45% 2,876 $0.32 $0.32 $0.29
    05 Nov 2026 $0.31 $0.01 3.33% 57,171 $0.30 $0.31 $0.30
    04 Nov 2026 $0.30 $0.00 0.00% 62,074 $0.30 $0.30 $0.28
    03 Nov 2026 $0.30 $0.01 3.45% 104,243 $0.31 $0.31 $0.29
    02 Nov 2026 $0.29 $0.00 0.00% 19,602 $0.29 $0.29 $0.29
    30 Oct 2026 $0.29 $-0.01 -3.33% 76,669 $0.31 $0.31 $0.29
    29 Oct 2026 $0.30 $0.00 0.00% 20,000 $0.30 $0.30 $0.30
    28 Oct 2026 $0.30 $0.00 0.00% 127,529 $0.30 $0.31 $0.29
    27 Oct 2026 $0.30 $0.01 3.45% 67,226 $0.30 $0.30 $0.29
    26 Oct 2026 $0.29 $0.01 3.51% 2,500 $0.29 $0.29 $0.29
    23 Oct 2026 $0.29 $-0.01 -3.45% 167,375 $0.29 $0.29 $0.28
    22 Oct 2026 $0.29 $0.00 0.00% 60,861 $0.29 $0.29 $0.28
    21 Oct 2026 $0.29 $0.05 21.28% 55,194 $0.27 $0.29 $0.27

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    25 Aug 2026 Michael Gordon Expiry 185,000 $62,900
    Options expired.
    25 Aug 2026 Gaetano (Guy) Russo Expiry 370,000 $125,800
    Options expired.
    25 Aug 2026 Benjamin(Ben) Gisz Expiry 185,000 $62,900
    Options expired.
    25 Aug 2026 Karen Borg Expiry 185,000 $62,900
    Options expired.
    23 Jul 2026 Karen Borg Buy 575,000 $270,250
    Exercise of options.
    23 Jul 2026 Karen Borg Exercise 575,000 $270,250
    Exercise of options.
    04 Dec 2025 Amrita Blickstead Issued 1,700,000 $1,360,000
    Issue of options.
    04 Dec 2025 Karen Borg Issued 1,700,000 $1,360,000
    Issue of options.
    04 Dec 2025 Andrew Price Issued 300,000 $240,000
    Issue of options.
    04 Dec 2025 Benjamin(Ben) Gisz Issued 200,000 $160,000
    Issue of options. As per announcement
    04 Dec 2025 Gaetano (Guy) Russo Issued 600,000 $480,000
    Issue of options.
    04 Dec 2025 Michael Gordon Issued 200,000 $160,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Gordon Non-Executive Director Aug 2020
    Mr Gordon is the Director of Koala Company Limited, a direct-to-consumer household goods retailer. He was previously the CFO of Rokt, a marketing technology company, and CFO of Different Technologies, a property technology company. Prior to these, Mr Gordon was the Group CFO and MD Group Services for Greenlit Brands Pty Limited. He started his career with PricewaterhouseCoopers, spending 10 years with them in South Africa, the United Kingdom and Australia specializing in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is a Chairman of the Risk Committee.
    Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
    Mr Russo has a commercial and customer-focused background working in Australia and internationally. Previously, he has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He has been a member of YPO since 2006, served as a member of the Business Council of Australia.
    Mr Andrew Price Non-Executive Director Jan 2025
    Mr Price has 25-year career at Resmed. His senior executive roles span global product development, project management and business development.
    Mr Benjamin(Ben) Gisz Non-Executive Director Oct 2024
    Mr Gisz is a director and member of the investment team at TDM Growth Partners, an investment firm specializing in long-term investments in high-growth companies globally. Ben has investment, corporate advisory and financial markets experience, including prior roles with Investec Group and Credit Suisse. Ben is a current Non-Executive Director at Australian pet supplies ecommerce business Pet Circle. He is a member of Risk Committee.
    Ms Karen Borg Executive DirectorChief Executive Officer Feb 2024
    Ms Borg has held senior roles in FTSE 100-250 medical devices, technology, consumer products and government services organizations. She was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Ms Borg began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing in Eastern Europe and Asia Pacific. She is on the Board of Optiscan Ltd and KOPWA Aged Care Services and was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance.
    Mr Terence Anthony Flitcroft Company Secretary
    -
    Ye-Fei Guo Chief Financial Officer
    -
    Terence Anthony Flitcroft Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 98,499,293 44.94%
    J P Morgan Nominees Australia Pty Limited 29,473,058 13.45%
    Dottie Investments Pty Ltd 9,166,619 4.18%
    Howarth PAF Pty Ltd <The Howarth Foundation A/C> 5,415,675 2.47%
    Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> 5,266,331 2.40%
    Ginga Pty Ltd <TG Klinger S/F A/C> 3,590,114 1.64%
    BNP Paribas Nominees Pty Ltd <Clearstream> 3,584,104 1.64%
    Timbina Pty Limited <Timbina Super Fund A/C> 2,696,297 1.23%
    Ginga Pty Ltd 2,434,216 1.11%
    Amrita Singh Blickstead 2,392,364 1.09%
    P Neustadt Holdings Pty Limited <Belgove Super Fund A/C> 2,353,628 1.07%
    Penn Nominees Pty Ltd <JB Parncutt Family Account> 2,131,386 0.97%
    Mr Gaetano Alfred Gerrard <Rusbev Super FD A/C> 2,055,220 0.94%
    Ginga Pty Ltd <TG Klinger S/F A/C> 1 2,000,000 0.91%
    Lion Nominees Pty Ltd <JB Parncutt Family Super Account> 1,990,099 0.91%
    Parncutt Family Foundation Pty Ltd < Pancutt Family Foundation Account> 1,739,800 0.79%
    Citicorp Nominees Pty Limited 1,685,781 0.77%
    Dinwoodie Investments Pty Ltd 1,628,164 0.74%
    Equity Plan Services Pty Ltd 1,597,307 0.73%
    UBS Nominees Pty Ltd 1,578,029 0.72%

    Profile

    since

    Note